Vapocoolant Spray to Reduce Pain With Nexplanon Insertion

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Reducing Pain With Nexplanon Implant Insertion

In brief

The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.

Key facts

Study ID

NCT06933381

Run by

Queen's Medical Center

People needed

70

Starts

2025-06-16

Expected to finish

2026-05-01

Last updated by the study team

2026-01-09

Who can join

Age: 14 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• At least 14 years or older
• Undergoing an etonogestrel implant insertion in the arm in POB1 Suite 1004 or POB2 Suite 402
• English speaking
• Able and willing to sign the informed consent form and agree to terms of the study

You may not qualify if…

• Required or requested narcotics, anxiolytics, IV sedation, or general anesthesia for the procedure
• Known previous exposure to vapocoolant spray
• Nexplanon removal and reinsertion same day during visit in the same arm
• Contraindications to vapocoolant spray components (ethyl chloride and 1,1,1,3,3-pentafluoropropane/1,1,1,2-tetrafluroethane)
• Unable to provide written, informed consent in English

Where it is running

• Queens Medical Center POB 2 Suite 402 — Honolulu, Hawaii, United States (enrolling)
• Queens Medical Center POB1 Clinic 1004 — Honolulu, Hawaii, United States (enrolling)
• Women's Center Queen's North Hawai'i Community Hospital Suite #124 and #120 — Waimea, Hawaii, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.